Estela Pineda

Featured publications

• Mutational profiling allows the stratification of metastatic colorectal cancer patients with poor prognosis

  Authors:

  Rodriguez Hernandez, A; LaHoz, S; Laia, F M; Gorria Puga, T; Moreno, R;

  (...)

  Pineda, E; Castells, A; Prat, A; Camps, J; Maurel, J.

  See complete list of authors

  Reference: Annals Of Oncology 2023.

• Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

  Authors:

  Martínez-Bosch, N; Alameda, F; Arumí-Uria, M; Bellosillo, B; Menéndez, S;

  (...)

  Hernández, A; Mesia, C; Esteve-Codina, A; de la Iglesia, N; Martínez-García, M.

  See complete list of authors

  Reference: Cells 2023.

• Photodynamic therapy in glioblastoma: Detection of intraoperative inadvertent 5-ALA mediated photodynamic therapeutical effect after gross total resection

  Authors:

  Ferres, Abel; Di Somma, Alberto; Mosteiro, Alejandra; Eduardo Topczewski, Thomaz; Roldan, Pedro;

  (...)

  Diao, Dioulde; Pineda, Estela; Sierra, Angels; Ensenat, Joaquim; Gonzalez-Sanchez, Jose Juan.

  See complete list of authors

  Reference: Frontiers In Oncology 2022.

• Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53-Mutated Metastatic Colorectal Cancer

  Authors:

  Lahoz, Sara; Rodriguez, Adela; Fernandez, Laia; Gorria, Teresa; Moreno, Reinaldo;

  (...)

  Postigo, Antonio; Castells, Antoni; Prat, Aleix; Maurel, Joan; Camps, Jordi.

  See complete list of authors

  Reference: Cancers 2022.

• A phase I-II multicenter trial with avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repairproficient (MSS) metastatic colorectal cancer patients. GEMCAD 16-02 (AVEVAC trial)

  Authors:

  Espanol-Rego, M; Fernandez-Martos, C; Elez Fernandez, M E; Foguet, C; Pedrosa, L;

  (...)

  Cuatrecasas, M; Torres, F; Cascante, M; Benitez-Ribas, D; Maurel, J.

  See complete list of authors

  Reference: Annals Of Oncology 2021.

• Long-term results of the GEINO 1401 TRIAL: Randomizing patients to stop or to continue temozolomide until 12 cycles.

  Authors:

  Domenech, M; Fabregat-Franco, C; Mesia, C; Esteve, A; Berron, SD;

  (...)

  Gonzalez, AH; Carrato, C; Sanz, C; Sanchez, JMS; Balana, C.

  See complete list of authors

  Reference: Journal Of Clinical Oncology 2021.

• Genetic profiling across multiple cancer types using molecular prescreening comprehensive gene panels offered by clinical trials (CT).

  Authors:

  Victoria, Ivan; Moreno Fernandez, Debora; Angelats, Laura; Indacochea, Alberto; Pelegrin, Francisco;

  (...)

  Martinez Saez, Olga; Baste Rotllan, Neus; Vinolas, Nuria; Nogue, Miquel; Garcia-Corbacho, Javier.

  See complete list of authors

  Reference: Journal Of Clinical Oncology 2021.

• Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT

  Authors:

  Molla, M; Cases, C; Conill, C; Pineda, E; Fernandez-Plana, J;

  (...)

  Fundora, Y; Vollmer, I; Garcia-Criado, A; Capdevila, J; Fernandez-Martos, C.

  See complete list of authors

  Reference: Journal Of Clinical Medicine 2021.

• Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment

  Authors:

  Rubio-Perez, C; Planas-Rigol, E; Bonfill-Teixidor, E; Arias, A; Serna, G;

  (...)

  Pineda, E; Martínez-Ricarte, F; Cordero, E; Cicuendez, M; Sahuquillo, J.

  See complete list of authors

  Reference: Nature Communications 2021.

• RNA-Sequencing and immunohistochemistry reveal ZFN7 as a stronger marker of survival than molecular subtypes in G-CIMP-negative glioblastoma

  Authors:

  Esteve-Codina, A; Dabad, M; Alameda, F; Bellosillo, B; Carrato, C;

  (...)

  Craven-Bartle, J; Villa, S; Marruecos, J; Domenech, S; de la Iglesia, N.

  See complete list of authors

  Reference: Clinical Cancer Research 2021.